Module 1 Flashcards
History of Pharmacology
- who is pharm used by
- chemists isolated substances when and how
- Effects of drugs were studied how
- Who were the earliest subjects
- Used by every culture, dating back to antiquity
- isolated pharm substances from natural substances in 1800
- tested on animals
- Early tests on themselves (the reseachers)
Canadian History
- Louis Hebert is considered what, born where, and came to Canada when
- What did he do
- The people who helped him were indigenous to where
- First apothecary born in Paris and moved to Quebec city in 1617
- looked after pioneers and made drugs shown to him by Mi’kmaq
- Indigenous to maritime provinces and Gaspé peninsula of Quebec
Pharmacology Now
- Drugs are made where
- Tested for how long
- Understanding has what
- focus is on what 2 (RI)
- made in labs
- tested over short times
- Understanding has increased of how drugs produce their effects
- focus on reliving suffering and improving quality of life
Conncection to Pharmacology
- The practice of using products to relieve suffering has been recorded where
- Pharm is intimately connected to what and is a key what
- The greater understanding of medicine does what
- Recorded throughout history by virtually every culture
- connected to nursing practice and is Key intervention in relieving and preventing human suffering
- More you understand meds the safer the pt
- What is pharmacology
- it includes (4) HWAH
Study of medicines
- how drugs are given
- where they go
- response produced
- how its eliminated from body
Four factors of complexity
- L
- C
- I
- D
- Large volume of drugs
- nomenclature can confuse communications between professions - Each drug (within the class) has its own characteristics
- Applications
- interactions
- side effects
- action - More than one indication
- Overlapping map of knowledge
- Cant diagnose by looking at med - Give different responses depending on factors
- age, sex, body mass, health status, genetics
Pharmacotherapeutics
Pharmacotherapy is the administration of drugs for either: (2) PT
It practices what kinds of medicine
Describe it
Administration for
- prevention of disease
- treatment of suffering
Practices Evidence - based medicine (EBM)
-Makes decisions according to well designed and conducted research
Three kinds of therapeutic agents DBN
- Drugs
- Prescription
- Over the counter - Biologics
- Natural health products
What is a drug
What is a medication
Made where
A drug is a chemical agent that produces a biological response
Meds are medically therapeutic drugs
Made in labs
Biologics
- Made with?
- Derived from?
- Examples
- Medications made using living organisms (yeast, bacteria)
- Complex large molecules derived from living things such as yeast and bacteria
Examples:
- Hormones (insulin)
- Monoclonal antibodies
- Natural blood products
- Interferon
- Vaccines
Natural Health Products
- examples
- How are they different from modern drugs
- any effect?
- vitamins, minerals, herbal remedies, homeopathic meds, traditions meds, probiotics supplements (amino acids, fatty acids, protein)
- Similar actions to modern drugs, regulated differently
- Can have clinically significant effects and side effects
Prescription Drugs
Advantages 3 and 2 disadvantages
Advantages
- Examines client and orders specific drug (personal)
- Amount and frequency controlled
- instructions on use, side effects identified and monitored
Disadvantages
- Require prescription
- An Appointment
Over the counter Drugs
Advantages 2 and 3 disadvantages
Advantages
- No appointment
- Less expensive
Disadvantage
- Can choose wrong drug
- May not know reactions
- Bad treatment = worse health
Canadian Drug Regulations
- What is the purpose
- when did the standard start
- what do some contain
- Purpose is to protect Canadian public
- Prior to the 19th century there were few standards
- Some drugs contain hazardous levels of dangerous and/or addictive substances
Governance structure
(Top to bottom)
3 parts
- Food and drugs Act & Regulations
- Health Canada
- Health Products & Food Branch
- Therapeutic products directorate
- Biologics & genetic therapies directorate
- Natural and Non-prescription Health Products Directorate
The Health Products and Food Branch
- Part of?
- Responsible for
- Regulates
- Part of Health Canada
- Responsible for ensuring health products and food are safe and of high quality
- Regulates the use of therapeutic products through directorates
Therapeutic Products Directorate (Health Products & Food Branch)
- Authorizes what
- Products must be proven to who
- Authorizes marketing of a pharmaceutical drug (both prescription and over-the-counter*) or medical device
- Products must be sufficiently scientifically proven (through clinical trials) to the Food and Drugs Act and Regulations
Biologics Genetic Therapies Directorate (Health Products & Food Branch)
- Regulates
- Examples of Biologics
- Examples of radiopharmaceuticals
- Regulates biologic drugs and radiopharmaceuticals
- Examples of biologics: blood products, vaccines, tissues, organ and gene therapy products
- Examples of radiopharmaceuticals: radioactive iodine for hyperthyroidism
Natural and Non-prescription Health Products Directorate (Health Products & Food Branch)
- Regulates?
- Conduct a review of what
- Also setup regulations for?
- Regulates the sale and use of natural health products (NHPs)
- Conduct a review of the safety and appropriate use of each product before it can be authorized for sale
- Also set up regulations for manufacturing within Canada or importation for sale in Canada
Prescription Drug Approval Process: New Drugs
6 step process PCCNHH
- Pre-Clinical Studies
- 3 to 5 years
- Test with cells of different species of animals
- Initial info on potential safety and effectiveness - Clinical Trial Application
- Submits detailed info on pre-clinical studies to health Canada
- Committee review info and authorize distribution - Clinical Trials
Phase 1 (20-100 healthy human volunteers in study)
-dosage is determined
-How drug is absorbed, distribution, metabolized and eliminated (ADME/ Pharmacokinetics) assessed
Phase 2 (100-300 volunteers who have disease)
- Dosage
- Side effects
Phase 3 (1000-3000 volunteers who have disease)
- Double blind study (placebo or conventional treatment)
- Clinical investigators assess results
- New drug submission
- Health Canada evaluates drugs safety, efficacy, quality - Health Canada issues permits to market drug product
-Issues notice of compliance (NOC)
-Issues drug identification number (DIN)
[Then released into market] - Health Canada monitors drug effectiveness and concerns post-marketing
- includes health professional adverse drug reaction reporting
Adverse Drug Reaction Reporting
Minimum info needed (4) PDNC
And helpful info
- Patient information – demographics but not name
- Description of the adverse event
- Name of the health product – when in doubt, report!
- Contact information for yourself
Other helpful info: dates of use of product (start & stop), dates of reaction, lab tests, other health products used
Patent
- What is a period of exclusivity
- What is the intention
- how long is the protection
- registered when
- What happens when it ends
- Once the periods ends what happens
- A period of exclusivity = where that pharmaceutical company only determines the price of the medication
- Intention of patents is for company to recover high costs of research and development of product (trials)
- Provides 20 years of patent protection; the actual length of exclusivity is ~ 7-9 years in Canada due to regulatory hurdles
- Must be registered any time before the New Drug Submission step(step 4) – each individual drug may be different depending upon legal advice
- Once that period of exclusivity ends, competing companies (generic companies) market the generic equivalent drug for less money, and consumer savings are considerable
Approval Process for Generics(Prescription and OTC)
- How long compared to standard process
- Must Prove what
- What is bioequivalent (2 parts) AB
- No need for clinical trials if
An abbreviated new drug submission
-Generic companies must prove their product is bioequivalent
- Bioequivalent = the rate and extent to which the active ingredient is
a) absorbed from a drug product, and
b) becomes available at the site of drug action to produce its effect
*no need for clinical trials if proved bioequivalent
Generic Products
- Can be safely used instead of
- cautious when
-the generic equivalent may be safely substituted for the trade name drug (HCP opinion)
Cautious when:
- critical, acute care drugs
- those with a narrow therapeutic window/range